IP Library Granted Patent US 12,122,769
Granted Patent B2
US 12,122,769 · App. 17/881,462 · Granted Oct 22, 2024

Synthesis of antibacterial aminoglycoside analogs

Inventors: Raissa Trend (Warren, NJ); Michael Dappen (Warren, NJ); Christopher E. Henry (Warren, NJ); Adam Aaron Goldblum (Warren, NJ); James Bradley Aggen (Warren, NJ); Ricardo Filipe De Jesus Gonçalves Mendonça (Warren, NJ); João Carlos Falcão Sardinha (Warren, NJ)
Assignee: CIPLA USA, INC.
C07D407/12C07B2200/13
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,122,769
App. No.
17/881,462
Granted
Oct 22, 2024
Kind
B2
Abstract

The present disclosure relates to novel methods for preparing antibacterial aminoglycoside compounds, as well as to related intermediates, and crystal forms thereof, useful in such methods.

Claims (44)

1. A process for preparing a compound of formula (2), or a salt thereof, or solvate thereof, or an enantiomer thereof, or a diastereomer thereof comprising:

(a) contacting a compound of formula (1):

or an enantiomer thereof, or a diastereomer thereof, with 1-{[(p-nitrobenzyl)oxy]carbonyl}-1H-benzotriazole (PNZ-Bt) to form the compound of formula (2):

or a salt thereof, or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof;

wherein - - - is a single bond or a double bond;

R 1 is H or C 1 -C 3 alkyl;

R 2 is H or C 1 -C 3 alkyl; and

R 3 is H or C 1 -C 3 alkyl.

2. The process of claim 1 , wherein step (a) is performed in the presence of a solvent selected from the group consisting of dichloromethane, methanol, and a combination thereof.

3. The process of claim 1 , further comprising step (b1) or (b2):

(b1) wherein when R 1 , R 2 , and R 3 are H, contacting the compound of formula (2) with a Boc protecting group reagent to yield a compound of formula (3):

or a salt thereof, or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof; or

(b2) wherein when one or more of R 1 , R 2 , or R 3 is independently a C 1 -C 3 alkyl, first removing said C 1 -C 3 alkyl, and then contacting the compound of formula (2), or a salt thereof, or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof, with a Boc protecting group reagent to yield a compound of formula (3):

or a salt thereof, or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof.

4. The process of claim 3 , wherein step (b1) or (b2) is performed in the presence of a Lewis acid.

5. The process of claim 3 , further comprising:

(c) contacting the compound of formula (3), or a salt thereof, or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof, with

 to yield a compound of formula (4):

or a salt thereof, or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof.

6. The process of claim 5 , wherein step (c) is performed in the presence of an activating reagent and a peptide coupling reagent.

7. The process of claim 5 , wherein step (c) is performed in an acidic condition.

8. The process of claim 5 , further comprising preparing a crystalline form of compound of formula (4), or a salt thereof, or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof.

9. The process of claim 5 , further comprising:

(d) contacting the compound of formula (4), or a salt thereof, or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof, with Boc protecting group reagent to yield a compound of formula (5):

or a salt thereof, or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof.

10. The process of claim 9 , wherein step (d) is performed in the presence of an alcohol.

11. The process of claim 9 , further comprising:

(e) contacting the compound of formula (5), or a salt thereof, or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof, with a PNZ deprotecting reagent to yield a compound of formula (6):

or a salt thereof, or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof; and

further comprising preparing a crystalline form of compound of formula (6), or a salt thereof, or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof.

12. The process of claim 11 , further comprising:

(f) contacting the compound of formula (6), or a salt thereof, or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof, with

wherein LG 1 is a leaving group, to yield a compound of formula (7):

or a salt thereof, or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof.

13. The process of claim 12 , further comprising:

(g) contacting the compound of formula (7), or a salt thereof, or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof, with a Boc removing reagent to yield a compound of formula (8):

or a salt thereof, or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof; and

(h) performing a salt formation with an acid to yield a salt of a compound of formula (8), or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof.

14. The process of claim 13 , wherein the Boc removing reagent is TFA, thereby yielding a TFA salt of compound of formula (8), or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof; and

(h) performing a salt formation with an acid to yield a salt of a compound of formula (8), or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof.

15. The process of claim 1 , wherein - - - is a double bond.

16. The process of claim 1 , wherein the stereochemistry at carbon atoms 1, 3, 4, 5, 6, 1′, 2′, 1″, 2″, 3″, and 4″ in formulae (1)-(3) are indicated as in formula (X), wherein indicates a point of attachment to hydrogen or a moiety:

17. The process of claim 14 , wherein the acid in step (h) is sulfuric acid, thereby yielding a sulfate salt of a compound of formula (9):

or a solvate thereof, or an enantiomer thereof, or a diastereomer thereof, wherein x is 1 to 5.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2024
From: TREND, RAISSA; DAPPEN, MICHAEL; HENRY, CHRISTOPHER E.; GOLDBLUM, ADAM AARON; AGGEN, JAMES BRADLEY
To: ACHAOGEN, INC.
Reel/Frame 067092/0094 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2024
From: MENDONÇA, RICARDO FILIPE DE JESUS GONÇALVES; SARDINHA, JOÃO CARLOS FALCÃO
To: HOVIONE FARMACIENCIA SA
Reel/Frame 067092/0104 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2024
From: HOVIONE FARMACIENCIA SA
To: HOVIONE INTER LTD
Reel/Frame 067092/0113 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2024
From: HOVIONE INTER LTD
To: ACHAOGEN, INC.
Reel/Frame 067092/0118 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2024
From: ACHAOGEN, INC.
To: CIPLA USA, INC.
Reel/Frame 067095/0418 →
Continuity (4)
Continuation 16850771 · Apr 16, 2020
Continuation PCTUS2018056536 · Oct 18, 2018
Provisional Application 62574544 · Oct 19, 2017
Related Publication 20230074115A1 · Mar 9, 2023